News > Research buzz > Third COVID-19 vaccine dose effectively boosts immunity for the majority of patients with cancer

Third COVID-19 vaccine dose effectively boosts immunity for the majority of patients with cancer

Nearly 100% of cancer patients with solid tumours have antibodies effective against the Delta variant after a third dose of COVID-19 vaccine, according to new results published in Cancer Cell.

	23 Dec 2021
	United Kingdom
	Research buzz

To view this News Article please log in or create a profile

Login

Join

Similar stories

Research buzz

Researchers develop way to selectively target diseased cells in motor neurone disease

Mouse neuron grown on coverslips. The dots of colour are individual synapses. More...

New tool reveals how breast and lung tumours avoid immune detection

Researchers at the Crick and UCL have developed a tool to analyse a key set of genes linked to the ability of cancer cel… More...

Credit: Christophe Galichet, PLOS Genetics.

Research reveals impact of gut microbiome on hormone levels in mice

Researchers at the Crick have shown that the balance of bacteria in the gut can influence symptoms of hypopituitarism in… More...

Self-repairing mitochondria use novel recycling system

More...

Villi in the mouse small intestine - nuclei in blue, Arid3a expression in red, goblet cells in green

Key gene identified for regeneration and repair of mouse intestine

Researchers at the Crick have identified a key gene for the renewal of cells in the mouse intestine to repair the gut af… More...

Have your say

Share your story, opinions, ideas, news and more. Please submit your content below, which will be sent to a community manager and turned into a story for the website or content for an email newsletter

News category:

(At least 596 x 372 pixels and max. 2MB)